CAF, MCF-10A, ZR-75-1, HCT116, QBC939, NCCIT, RBE, HUCCT1, ZJU-0826, and ZJU-1125 cells were washed thrice with ice-cold phosphate buffered saline (PBS), lysed in RIPA buffer containing 50 mM Tris (pH 7.4), 150 mM NaCl, 0.5% sodium deoxyholate, 1% Nonide P-40, and 0.1% SDS with Pierce Protease Inhibitor Tablets (AEBSF,
aprotinin,
bestatin, E-64,
leupeptin, and pepstain A) (Thermo Fisher Scientific Inc., Waltham, MA, USA) and separated by centrifugation. The protein concentration was detected using the
BCA Protein Assay Kit (Thermo Fisher Scientific Inc). Antibodies against the following proteins were used:
E-cadherin,
N-cadherin,
β-catenin, α-SMA, MUC1,
CD146,
SOX17, Vitamin D3 Receptor (VDR), pdx1,
CD326, FoxA1/HNF3α,
FoxA2/HNF3β,
Nanog,
GAPDH, and
β-actin (all 1:1000, from Cell Signaling Technology, Danvers, MA, USA).
Flow cytometry was performed using a
FACScan instrument (BD Bioscience, San Jose, CA, USA) and commercially available reagents for cells at passages 3–5 and 60–65. A panel of monoclonal antibodies was evaluated, including CD24, CD44, CD29, CD34, CD90,
CD117,
CD133,
CD184,
CD326, and CD338 (Biolegend, San Diego, CA, USA). Antigen expression was determined based on a significant shift in staining compared to an isotype control.
Zhang Y., Luo J., Dong X., Yang F., Zhang M., Zhao J., Wang Q., Zhou F., Sun J, & Yang X. (2019). Establishment and Characterization of Two Novel Cholangiocarcinoma Cell Lines. Annals of Surgical Oncology, 26(12), 4134-4147.